Biomedical and healthtech projects qualify as R&D when conducting systematic investigation to gain new knowledge about biological phenomena, develop diagnostic tools, or create medical technologies with uncertain outcomes.
What Qualifies as R&D
Understanding what qualifies as R&D is crucial for maximizing your tax credits. In Biomedical & Life Sciences / Healthtech, innovation takes many forms—from breakthrough algorithms to novel system architectures. Here's what the UAE tax authorities recognize as eligible R&D activities:
Diagnostic Tool Development: Creating new algorithms for disease detection, developing novel imaging analysis methods, or building AI models for clinical decision support
Biomarker Discovery: Systematic investigation to identify new biological indicators, validation studies, or developing measurement methodologies
Medical Device Innovation: Designing new devices or substantially improving existing ones through experimental engineering (pre-clinical and clinical validation phases)
Clinical Validation Software: Developing algorithms that analyze clinical data, creating patient monitoring systems, or building predictive models for treatment outcomes
Genomic Analysis Tools: Creating new bioinformatics algorithms, developing novel sequencing analysis methods, or building personalized medicine platforms
Laboratory Research: Experimental work to understand disease mechanisms, test new compounds, or validate therapeutic approaches
Digital Therapeutics: Developing evidence-based therapeutic interventions delivered through software where clinical efficacy must be established
The Five Core Criteria
Your work must satisfy all five criteria established by the Frascati Manual—the international standard for R&D classification. Here's how these apply to your industry:
Novel (Frascati 2.14)
You're discovering new biomarkers, developing unprecedented diagnostic approaches, or creating medical technologies that advance beyond current capabilities
Creative (Frascati 2.17)
The work requires specialized scientific expertise to design experiments, interpret results, and develop new methodologies—not routine medical practice
Uncertain (Frascati 2.18)
Clinical outcomes cannot be predicted, biological responses may vary, and you don't know if hypotheses will be confirmed. This distinguishes research from routine medical care
Systematic (Frascati 2.19)
Studies follow protocols, maintain ethical approvals, document methodologies, track patient data systematically, and allocate research budgets formally
Transferable & Reproducible (Frascati 2.20)
Results can be published in scientific journals, documented in clinical trial registries, or protected through patents, allowing other researchers to validate and build upon findings
Common Misconceptions
Not every development activity qualifies as R&D. It's important to understand the boundaries. The following activities, while valuable to your business, don't meet the criteria for R&D tax credits:
Routine clinical care and patient treatment
Standard diagnostic testing using established methods
Quality control of medical devices in production
Routine autopsies to determine cause of death
Administrative healthcare operations
Standard data collection without investigational intent
Compliance documentation for regulatory submissions (unless part of validation studies)
The Documentation Challenge
Even when your work clearly qualifies, inadequate documentation can cost you thousands in lost credits. We've seen brilliant innovations go unclaimed simply because teams didn't capture the right evidence. Here's what we've learned from working with hundreds of Biomedical & Life Sciences / Healthtech companies:
Common Pain Points
Separating research time from clinical care activities
Meeting both R&D documentation and regulatory requirements (FDA, CE, SFDA)
Maintaining data retention under HIPAA/GDPR while proving R&D
Documenting ethical approvals and informed consent processes
Tracking costs across multiple study phases
Managing complex trials with multiple investigators and sites
Best Practices That Work
Maintain detailed study protocols with objectives, methodologies, and success criteria
Document institutional review board (IRB) approvals and amendments
Keep comprehensive lab notebooks with experimental procedures and observations
Record negative results and failed hypotheses (demonstrate uncertainty)
Track investigator time allocation between research and clinical duties
Maintain version control for study protocols and analysis methods
Document device iterations and design changes with technical rationale
How We Make It Easy
RDvault was built by engineers who understand the unique challenges of documenting technical work. We automate the tedious parts so you can focus on innovation.
Structured evidence storage compliant with healthcare regulations
Version control for study protocols, case report forms, and analysis plans
Linking staff time to specific test cycles and study phases
Integration with electronic lab notebooks (ELN) and LIMS systems
Secure handling of de-identified patient data for R&D evidence
Automated extraction of technical details from regulatory submissions
Does Your Project Qualify?
Ask yourself these five questions. If you answer yes to most of them, you're likely sitting on unclaimed R&D credits:
Are you researching, testing, or validating something with scientific uncertainty?
Does your work aim to discover new knowledge about biological systems or disease?
Are you developing or substantially improving diagnostic/therapeutic tools?
Is the work conducted under protocols with defined hypotheses and methodologies?
Do you have researchers (not just clinical practitioners) leading the investigation?
Ready to Claim What You've Earned?
Join forward-thinking Biomedical & Life Sciences / Healthtech companies already maximizing their R&D credits with RDvault. Get your personalized eligibility assessment in minutes.